SCHEMBL14613670

SCHEMBL14613670

CC(C)(O)c1ccc(N(CC(F)(F)F)S(=O)(=O)c2ccccc2Cl)cc1

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 11/20 0.82
NR1I2 O75469 6/20 0.71
NR1H2 P55055 5/20 0.58
RORC P51449 4/20 0.56
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
RXRA P19793 1/20 0.54
RORA P35398 1/20 0.54
SREBF1 P36956 1/20 0.54
PSEN1 P49768 1/20 0.54
PSEN2 P49810 1/20 0.54
NR1H3 Q13133 1/20 0.54
NR1I3 Q14994 1/20 0.54
APH1B Q8WW43 1/20 0.54
NCSTN Q92542 1/20 0.54
RORB Q92753 1/20 0.54
APH1A Q96BI3 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
PSENEN Q9NZ42 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14613669 0.90 HSD11B1 (0.68) HSD11B1NR1I2NR1H2RORCALDH1A1
SCHEMBL5564305 0.90 HSD11B1 (1.00) HSD11B1NR1I2NR1H2RORCALDH1A1
SCHEMBL14613566 0.86 HSD11B1 (0.61) HSD11B1NR1I2NR1H2RORCRORA
SCHEMBL5564186 0.81 HSD11B1 (0.83) HSD11B1NR1I2NR1H2RORCALDH1A1
SCHEMBL4611779 0.79 HSD11B1 (0.80) HSD11B1NR1I2NR1H2RORCRORA
SCHEMBL5564300 0.76 HSD11B1 (0.76) HSD11B1NR1I2NR1H2RORC
SCHEMBL5565824 0.75 HSD11B1 (1.00) HSD11B1NR1I2NR1H2NR1H3
SCHEMBL13651537 0.73 NR1I2 (1.00) HSD11B1NR1I2NR1H2RORCALDH1A1
SCHEMBL4598847 0.72 HSD11B1 (0.75) HSD11B1NR1H2NR1H3
SCHEMBL16121117 0.72 NR1H3 (0.68) HSD11B1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007013929-A1 ANILINE SULFONAMIDE DERIVATIVES AND THEIR USES AMGEN INC. (US) 2007-02-01 WO disclosed